Innsbruck Medical University
Research in oncology provides new insights
Published in Lab Business Week, February 5th, 2006
Study 1: Tumor necrosis factor-alpha (TNF-alpha) impacts survival in patients with myelodysplastic syndromes (MDS).
"An excessive intramedullar progenitor cell apoptosis, to which elevated expression of TNF-alpha might contribute, is considered the main cause of inefficient hematopoiesis in MDS. Enhanced bone marrow (BM) angiogenesis is regarded as an essential cofactor in the progression of MDS to acute myelogenous leukemia (AML) and microvessel formation may be induced by TNF-alpha as well," scientists in Austria report.
"To investigate TNF-alpha...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2006-02-05)
More Articles from Lab Business Week
- Access Pharmaceuticals, Inc.
Access Pharmaceuticals granted hearing with AMEX to maintain its listing - Actavis Group
Generic pharmaceutical firm completes syndication of $1.3B acquisition facility - Affymetrix, Inc.
DNA analysis systems maker expects fourth quarter revenue to be below previous guidance - Akesis Pharmaceuticals, Inc.
Diabetes drug maker announces $4M private placement - Albany Molecular Research, Inc.
Small molecule drug developer accelerates vesting of certain stock options - Allergan, Inc.
Dermatology drug developer extends expiration date of exchange offer for Inamed Corp. - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
